Remove Competition Remove Leads Remove Manufacturing Remove Pharma
article thumbnail

Is the pharmaceutical sector realising its potential for sustainable manufacturing?

European Pharmaceutical Review

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. 1 Every major pharmaceutical manufacturer in the UK and Ireland is investing in making their operations and supply chains more environmentally friendly.

article thumbnail

Global pharma confidence highest on record, shows CPhI Pharma Index

European Pharmaceutical Review

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Competitiveness. Key countries. Finished Dosage. Growth potential.

Pharma 79
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ESG in pharma: Meeting increasing requirements in the Nordic region

Pharmaceutical Technology

Nordic healthcare providers are leading the momentum in enhancing ESG considerations. We examine the regional developments that will provide a competitive edge to pharma manufacturers.

Pharma 52
article thumbnail

Embracing automation in sterile manufacturing

European Pharmaceutical Review

In the interview, conducted at CPHI Barcelona, Krishna Venkatesh, Global Head, Sterile Manufacturing Operations at Dr Reddy’s Laboratories explores industry’s growing focus on achieving end-to-end connectivity, as well as the potential of automation and track and trace solutions. What trends are you seeing in the pharma space?

article thumbnail

Leading payers in the pharmaceutical industry

Pharmaceutical Technology

Pharmaceutical Technology has listed the leading payers in pharma based on its intel, insights, and decades-long experience in the sector. Competitive intelligence studies. Payers in pharma can be categorised broadly into three types based on their functionality – national payers, regional payers and local payers.

Leads 59
article thumbnail

Cell and gene therapy: manufacturing and talent trends 2023

European Pharmaceutical Review

o find out about the current trends in cell and gene therapy manufacturing, EPR spoke to Cell and Gene Therapy Catapult (CGT Catapult)’s Chief Manufacturing Officer, Stephen Ward, and Chief Business Officer, Jeanette Evans. Licensing of the manufacturing suites is expected in early 2024. So now we have a really nice blend.”

article thumbnail

The Second Order Effects of the Inflation Reduction Act: What Uncertainties Does Pharma Need to Plan For?

PM360

To prepare for the second order effects of the IRA, one important step that we recommend for manufacturers is to clearly articulate and outline the remaining uncertainties regarding how the IRA will be implemented by CMS and identify scenarios most likely to impact their products. Acceptance and Consideration of Manufacturer Evidence.